The F.D.A. is likely to issue an emergency approval, a senior official said. But another study found the drug offered no benefit to severely ill patients.
Iconic One Theme | Powered by Wordpress
The F.D.A. is likely to issue an emergency approval, a senior official said. But another study found the drug offered no benefit to severely ill patients.